EXHIBIT 1 SEGMENTATION OF GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH (2022)
EXHIBIT 3 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY: MARKET SHARE 2022–2028 (%)
EXHIBIT 4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE: MARKET SHARE 2022–2028 (%)
EXHIBIT 5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA: MARKET SHARE 2022–2028 (%)
EXHIBIT 6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE: MARKET SHARE 2022–2028 (%)
EXHIBIT 7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND: MARKET SHARE 2022–2028 (%)
EXHIBIT 8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY: MARKET SHARE 2022–2028 (%)
EXHIBIT 9 BIOTECH API MANUFACTURING PROCESS
EXHIBIT 10 SYNTHETIC API MANUFACTURING PROCESS
EXHIBIT 11 IMPACT OF DIGITAL TRANSFORMATION OF PHARMACEUTICAL API INDUSTRY
EXHIBIT 12 BENEFITS OF DIGITAL TRANSFORMATION FOR BUSINESS DEVELOPERS
EXHIBIT 13 IMPACT OF INCREASED ADOPTION OF BIOSIMILARS
EXHIBIT 14 IMPACT OF DEMAND FOR NOVEL APIS
EXHIBIT 15 GLOBAL LAUNCHES OF NOVEL ACTIVE SUBSTANCES (NASS) 2013–2022
EXHIBIT 16 IMPACT OF TECHNOLOGICAL ADVANCES IN API MANUFACTURING
EXHIBIT 17 IMPACT OF DEMAND FOR GENERIC DRUGS
EXHIBIT 18 PENETRATION RATE OF GENERICS BY COUNTRIES IN 2019 (%)
EXHIBIT 19 GENERICS OPPORTUNITY BASED ON PATENT EXPIRATION BETWEEN 2020 AND 2026 BY THERAPY AREA (%)
EXHIBIT 20 IMPACT OF GROWTH OF PHARMACEUTICAL INDUSTRY
EXHIBIT 21 GLOBAL PHARMACEUTICAL INDUSTRY SIZE 2015–2025 ($ BILLION)
EXHIBIT 22 GLOBAL APIS MANUFACTURERS: R&D EXPENDITURE 2020–2022 ($ MILLION)
EXHIBIT 23 IMPACT OF INCREASED API OUTSOURCING OPERATIONS
EXHIBIT 24 IMPACT OF STRINGENT GOVERNMENT REGULATIONS
EXHIBIT 25 IMPACT OF LOW PROFIT MARGINS & HIGH API-MANUFACTURING COSTS
EXHIBIT 26 IMPACT OF ANALYTICAL CHALLENGES IN TESTING PROCESSES
EXHIBIT 27 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 28 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE: MARKET OPPORTUNITY
EXHIBIT 29 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA: MARKET OPPORTUNITY
EXHIBIT 30 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE: MARKET OPPORTUNITY
EXHIBIT 31 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND: MARKET OPPORTUNITY
EXHIBIT 32 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY: MARKET OPPORTUNITY
EXHIBIT 33 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY: MARKET OPPORTUNITY
EXHIBIT 34 FIVE FORCES ANALYSIS 2022
EXHIBIT 35 INCREMENTAL GROWTH BY MOLECULE TYPE 2022 & 2028
EXHIBIT 36 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 37 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE: ABSOLUTE GROWTH (%)
EXHIBIT 38 GLOBAL SMALL MOLECULES/ CHEMICAL APIS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL SMALL MOLECULES/CHEMICAL APIS MARKET 2022–2028 ($ BILLION)
EXHIBIT 40 GLOBAL LARGE MOLECULES/ BIOLOGICAL APIS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL LARGE MOLECULES/BIOLOGICAL APIS 2022–2028 ($ BILLION)
EXHIBIT 42 INCREMENTAL GROWTH BY THERAPY AREA 2022 & 2028
EXHIBIT 43 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 44 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA: ABSOLUTE GROWTH (%)
EXHIBIT 45 GLOBAL CARDIOVASCULAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL CARDIOVASCULAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 47 GLOBAL ONCOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL ONCOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 49 GLOBAL NEUROLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 50 GLOBAL NEUROLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 51 GLOBAL ANTI-INFECTIVES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 52 GLOBAL ANTI-INFECTIVES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 53 GLOBAL ENDOCRINOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL ENDOCRINOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 55 GLOBAL PULMONOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL PULMONOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 57 GLOBAL OTHER THERAPY AREAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 58 GLOBAL OTHER THERAPY AREAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 59 INCREMENTAL GROWTH BY MANUFACTURER TYPE 2022 & 2028
EXHIBIT 60 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 61 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE: ABSOLUTE GROWTH (%)
EXHIBIT 62 GLOBAL CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 63 GLOBAL CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 64 GLOBAL MERCHANT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 65 GLOBAL MERCHANT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 66 INCREMENTAL GROWTH BY BRAND 2022 & 2028
EXHIBIT 67 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 68 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND: ABSOLUTE GROWTH (%)
EXHIBIT 69 GLOBAL PATENTED/INNOVATIVE APIS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 70 GLOBAL PATENTED/INNOVATIVE APIS MARKET 2022–2028 ($ BILLION)
EXHIBIT 71 GLOBAL GENERIC APIS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 72 GLOBAL GENERIC APIS MARKET 2022–2028 ($ BILLION)
EXHIBIT 73 INCREMENTAL GROWTH BY POTENCY 2022 & 2028
EXHIBIT 74 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 75 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY: ABSOLUTE GROWTH (%)
EXHIBIT 76 GLOBAL NON-POTENT APIS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 77 GLOBAL NON-POTENT APIS MARKET 2022–2028 ($ BILLION)
EXHIBIT 78 GLOBAL HIGHLY POTENT APIS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 79 GLOBAL HIGHLY POTENT APIS MARKET 2022–2028 ($ BILLION)
EXHIBIT 80 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 81 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 82 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 83 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: KEY COUNTRIES IN 2022 ($ BILLION)
EXHIBIT 84 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: KEY COUNTRIES ($ BILLION)
EXHIBIT 85 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 86 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 87 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028
EXHIBIT 88 US ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 89 CANADA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 90 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: KEY COUNTRIES ($ BILLION)
EXHIBIT 91 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 92 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 93 INCREMENTAL GROWTH IN APAC 2022 & 2028
EXHIBIT 94 CHINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 95 INDIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 96 JAPAN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 97 SOUTH KOREA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 98 AUSTRALIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 99 INDONESIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 100 SINGAPORE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 101 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: KEY COUNTRIES ($ BILLION)
EXHIBIT 102 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 103 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 104 INCREMENTAL GROWTH IN EUROPE 2022 & 2028
EXHIBIT 105 GERMANY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 106 UK ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 107 RUSSIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 108 FRANCE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 109 SPAIN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 110 ITALY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 111 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: KEY COUNTRIES ($ BILLION)
EXHIBIT 112 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 113 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 114 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028
EXHIBIT 115 BRAZIL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 116 MEXICO ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 117 ARGENTINA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 118 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: KEY COUNTRIES ($ BILLION)
EXHIBIT 119 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 120 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 121 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2022 & 2028
EXHIBIT 122 TURKEY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 123 SAUDI ARABIA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 124 UAE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 125 SOUTH AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET 2022–2028 ($ BILLION)
EXHIBIT 126 ABBVIE: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 127 ABBVIE: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 128 BOEHRINGER INGELHEIM: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 129 BOEHRINGER INGELHEIM: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 130 BOEHRINGER INGELHEIM: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)
EXHIBIT 131 BOEHRINGER INGELHEIM: REVENUE BY GEOGRAPHIC REGION 2022 ($ BILLION)
EXHIBIT 132 BRISTOL-MYERS SQUIBB COMPANY: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 133 BRISTOL-MYERS SQUIBB COMPANY: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 134 ELI LILLY AND COMPANY: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 135 ELI LILLY AND COMPANY: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 136 ELI LILLY AND COMPANY: REVENUE BY GEOGRAPHIC REGION 2022 ($ BILLION)
EXHIBIT 137 GSK: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 138 GSK: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 139 MERCK KGAA: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 140 MERCK KGAA: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 141 MERCK KGAA: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)
EXHIBIT 142 MERCK KGAA: REVENUE BY GEOGRAPHIC REGION 2022 ($ BILLION)
EXHIBIT 143 NOVARTIS: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 144 NOVARTIS: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 145 NOVARTIS: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)
EXHIBIT 146 NOVARTIS: REVENUE BY GEOGRAPHY 2022 ($ BILLION)
EXHIBIT 147 PFIZER: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 148 PFIZER: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 149 PFIZER: REVENUE BY BUSINESS SEGMENT 2021 ($ BILLION)
EXHIBIT 150 PFIZER: REVENUE BY GEOGRAPHIC REGION 2021 ($ BILLION)
EXHIBIT 151 SANOFI: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 152 SANOFI: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 153 SANOFI: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)
EXHIBIT 154 SANOFI: REVENUE BY GEOGRAPHIC REGION 2022 ($ BILLION)
EXHIBIT 155 SUN PHARMACEUTICAL INDUSTRIES: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 156 SUN PHARMACEUTICAL INDUSTRIES: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 157 VIATRIS: TOTAL REVENUE 2020–2022 ($ BILLION)
EXHIBIT 158 VIATRIS: R&D EXPENDITURE 2020–2022 ($ BILLION)
EXHIBIT 159 VIATRIS: REVENUE BY BUSINESS SEGMENT 2022 ($ BILLION)
EXHIBIT 160 VIATRIS: REVENUE BY GEOGRAPHIC REGION 2022 ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2016–2022
TABLE 3 SUMMARY OF CROSS-COUNTRY ANALYSIS
TABLE 4 NUMBER OF BLOCKBUSTER & SMALL-MOLECULE DRUGS GOING-OFF PATENT GLOBALLY
TABLE 5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE: MARKET SIZE 2022 & 2028
TABLE 6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA: MARKET SIZE 2022 & 2028
TABLE 7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE: MARKET SIZE 2022 & 2028
TABLE 8 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND: MARKET SIZE 2022 & 2028
TABLE 9 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY: MARKET SIZE 2022 & 2028
TABLE 10 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY: MARKET SIZE 2022 & 2028
TABLE 11 GLOBAL SMALL MOLECULES/CHEMICAL APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 12 GLOBAL SMALL MOLECULES/CHEMICAL APIS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 13 GLOBAL LARGE MOLECULES/BIOLOGICAL APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 14 GLOBAL LARGE MOLECULES/BIOLOGICAL APIS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 15 GLOBAL CARDIOVASCULAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 16 GLOBAL CARDIOVASCULAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 17 GLOBAL ONCOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 18 GLOBAL ONCOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 19 GLOBAL NEUROLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 20 GLOBAL NEUROLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 21 GLOBAL ANTI-INFECTIVES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 22 GLOBAL ANTI-INFECTIVES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 23 GLOBAL ENDOCRINOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 24 GLOBAL ENDOCRINOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 25 GLOBAL PULMONOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 26 GLOBAL PULMONOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 27 GLOBAL OTHER THERAPY AREAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 28 GLOBAL OTHER THERAPY AREAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 29 GLOBAL CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 30 GLOBAL CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 31 GLOBAL MERCHANT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 32 GLOBAL MERCHANT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 33 GLOBAL PATENTED/INNOVATIVE APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 34 GLOBAL PATENTED/INNOVATIVE APIS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 35 GLOBAL GENERIC APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 36 GLOBAL GENERIC APIS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 37 GLOBAL NON-POTENT APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 38 GLOBAL NON-POTENT APIS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 39 GLOBAL HIGHLY POTENT APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 40 GLOBAL HIGHLY POTENT APIS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 41 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 ($ BILLION)
TABLE 42 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 (%)
TABLE 43 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 ($ BILLION)
TABLE 44 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 (%)
TABLE 45 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 ($ BILLION)
TABLE 46 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 (%)
TABLE 47 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 ($ BILLION)
TABLE 48 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 (%)
TABLE 49 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 ($ BILLION)
TABLE 50 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 (%)
TABLE 51 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 ($ BILLION)
TABLE 52 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 (%)
TABLE 53 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 ($ BILLION)
TABLE 54 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 (%)
TABLE 55 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 ($ BILLION)
TABLE 56 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 (%)
TABLE 57 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 ($ BILLION)
TABLE 58 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 (%)
TABLE 59 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 ($ BILLION)
TABLE 60 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 (%)
TABLE 61 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 ($ BILLION)
TABLE 62 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 (%)
TABLE 63 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 ($ BILLION)
TABLE 64 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 (%)
TABLE 65 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 ($ BILLION)
TABLE 66 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 (%)
TABLE 67 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 ($ BILLION)
TABLE 68 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 (%)
TABLE 69 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 ($ BILLION)
TABLE 70 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 (%)
TABLE 71 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 ($ BILLION)
TABLE 72 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 (%)
TABLE 73 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 ($ BILLION)
TABLE 74 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 (%)
TABLE 75 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 ($ BILLION)
TABLE 76 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 (%)
TABLE 77 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 ($ BILLION)
TABLE 78 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 (%)
TABLE 79 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 ($ BILLION)
TABLE 80 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 (%)
TABLE 81 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 ($ BILLION)
TABLE 82 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 (%)
TABLE 83 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 ($ BILLION)
TABLE 84 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 (%)
TABLE 85 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 ($ BILLION)
TABLE 86 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 (%)
TABLE 87 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 ($ BILLION)
TABLE 88 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 (%)
TABLE 89 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 ($ BILLION)
TABLE 90 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 (%)
TABLE 91 ABBVIE: MAJOR PRODUCT OFFERINGS
TABLE 92 BOEHRINGER INGELHEIM: MAJOR PRODUCT OFFERINGS
TABLE 93 BRISTOL-MYERS SQUIBB COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 94 CIPLA: MAJOR PRODUCT OFFERINGS
TABLE 95 ELI LILLY AND COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 96 GSK: MAJOR PRODUCT OFFERINGS
TABLE 97 MERCK KGAA: MAJOR PRODUCT OFFERINGS
TABLE 98 NOVARTIS: MAJOR PRODUCT OFFERINGS
TABLE 99 PFIZER: MAJOR PRODUCT OFFERINGS
TABLE 100 SANOFI: MAJOR PRODUCT OFFERINGS
TABLE 101 SUN PHARMACEUTICAL INDUSTRIES: MAJOR PRODUCT OFFERINGS
TABLE 102 MYLAN: MAJOR PRODUCT OFFERINGS
TABLE 103 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 ($ BILLION)
TABLE 104 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 (%)
TABLE 105 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 ($ BILLION)
TABLE 106 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 (%)
TABLE 107 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 ($ BILLION)
TABLE 108 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 (%)
TABLE 109 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 ($ BILLION)
TABLE 110 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 (%)
TABLE 111 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 ($ BILLION)
TABLE 112 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 (%)
TABLE 113 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 ($ BILLION)
TABLE 114 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MOLECULE TYPE 2022–2028 (%)
TABLE 115 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 ($ BILLION)
TABLE 116 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 (%)
TABLE 117 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 ($ BILLION)
TABLE 118 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 (%)
TABLE 119 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 ($ BILLION)
TABLE 120 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 (%)
TABLE 121 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 ($ BILLION)
TABLE 122 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 (%)
TABLE 123 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 ($ BILLION)
TABLE 124 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 (%)
TABLE 125 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 ($ BILLION)
TABLE 126 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY THERAPY AREA 2022–2028 (%)
TABLE 127 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 ($ BILLION)
TABLE 128 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 (%)
TABLE 129 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 ($ BILLION)
TABLE 130 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 (%)
TABLE 131 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 ($ BILLION)
TABLE 132 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 (%)
TABLE 133 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 ($ BILLION)
TABLE 134 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 (%)
TABLE 135 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 ($ BILLION)
TABLE 136 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 (%)
TABLE 137 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 ($ BILLION)
TABLE 138 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY MANUFACTURER TYPE 2022–2028 (%)
TABLE 139 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 ($ BILLION)
TABLE 140 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 (%)
TABLE 141 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 ($ BILLION)
TABLE 142 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 (%)
TABLE 143 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 ($ BILLION)
TABLE 144 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 (%)
TABLE 145 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 ($ BILLION)
TABLE 146 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 (%)
TABLE 147 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 ($ BILLION)
TABLE 148 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 (%)
TABLE 149 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 ($ BILLION)
TABLE 150 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY BRAND 2022–2028 (%)
TABLE 151 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 ($ BILLION)
TABLE 152 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 (%)
TABLE 153 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 ($ BILLION)
TABLE 154 NORTH AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 (%)
TABLE 155 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 ($ BILLION)
TABLE 156 APAC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 (%)
TABLE 157 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 ($ BILLION)
TABLE 158 EUROPE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 (%)
TABLE 159 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 ($ BILLION)
TABLE 160 LATIN AMERICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 (%)
TABLE 161 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 ($ BILLION)
TABLE 162 MIDDLE EAST & AFRICA ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY POTENCY 2022–2028 (%)
TABLE 163 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 164 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 165 GLOBAL SMALL MOLECULES/CHEMICAL APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 166 GLOBAL SMALL MOLECULES/ CHEMICAL APIS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 167 GLOBAL LARGE MOLECULES/BIOLOGICAL APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 168 GLOBAL LARGE MOLECULES/BIOLOGICAL APIS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 169 GLOBAL CARDIOVASCULAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 170 GLOBAL CARDIOVASCULAR ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 171 GLOBAL ONCOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 172 GLOBAL ONCOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 173 GLOBAL NEUROLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 174 GLOBAL NEUROLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 175 GLOBAL ANTI-INFECTIVES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 176 GLOBAL ANTI-INFECTIVES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 177 GLOBAL ENDOCRINOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 178 GLOBAL ENDOCRINOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 179 GLOBAL PULMONOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 180 GLOBAL PULMONOLOGY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 181 GLOBAL OTHER THERAPY AREAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 182 GLOBAL OTHER THERAPY AREAS ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 183 GLOBAL CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 184 GLOBAL CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 185 GLOBAL MERCHANT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 186 GLOBAL MERCHANT ACTIVE PHARMACEUTICAL INGREDIENTS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 187 GLOBAL PATENTED/INNOVATIVE APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 188 GLOBAL PATENTED/INNOVATIVE APIS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 189 GLOBAL GENERIC APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 190 GLOBAL GENERIC APIS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 191 GLOBAL NON-POTENT APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 192 GLOBAL NON-POTENT APIS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 193 GLOBAL HIGHLY POTENT APIS MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 194 GLOBAL HIGHLY POTENT APIS MARKET BY GEOGRAPHY 2022–2028 (%)